Concurrent Investment Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Buy
7,349
+2,531
+53% +$672K 0.03% 531
2026
Q1
$528K Buy
4,818
+1,336
+38% +$190K 0.01% 1190
2025
Q4
$579K Sell
3,482
-756
-18% -$126K 0.01% 1081
2025
Q3
$830K Buy
4,238
+667
+19% +$110K 0.01% 711
2025
Q2
$323K Buy
+3,571
New +$282K 0.01% 1031

Other funds holding ALAB

Concurrent Investment Advisors's ALAB Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Astera Labs (ALAB) stake by 53% in Q2 2026, buying an estimated $672K and bringing the position to 7,349 shares worth $3.55M. The position accounts for 0.03% of the portfolio, ranked #531.

Concurrent Investment Advisors first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Concurrent Investment Advisors held 7,349 shares of Astera Labs worth $3.55M as of Q2 2026.
  • Concurrent Investment Advisors bought 2,531 Astera Labs shares in Q2 2026, an estimated $672K.
  • Astera Labs made up 0.03% of Concurrent Investment Advisors's portfolio in Q2 2026, its #531 holding.
  • Concurrent Investment Advisors first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.